Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)
CUSIP: 71722W107
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 27,258,631
- Total 13F value
- $230,064,222
- Share change
- +1,606,013
- SEC-reported price per share
- $8.44
- Number of holders
- 88
- Value change
- +$9,335,400
- Number of buys
- 51
- Number of sells
- 28
- Shares outstanding
- 79,611,764
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
88
Top holders
10
PHAT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Ownership snapshot
Top reported holders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frazier Life Sciences Man...
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F
Highest disclosed value: $79,311,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Frazier Life Sciences Management, L.P. has the largest disclosed position value at $79.31M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Disclosed position value
Top 5
Frazier Life Sciences Management,...
$79.31M
Medicxi Ventures Management (Jers...
$28.14M
Invesco Ltd.
$27.9M
Janus Henderson Group Ltd.
$27.24M
Avidity Partners Management LP
$26.48M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
Company
|
—
denominator unverified
|
$79,311,000
5,827,415 shares
|
— | 31 Mar 2022 |
| Medicxi Ventures Management (Jersey) Ltd |
13F
Company
|
—
denominator unverified
|
$28,143,000
2,067,861 shares
|
— | 31 Mar 2022 |
| Invesco Ltd. |
13F
Company
|
—
denominator unverified
|
$27,897,000
2,049,759 shares
|
— | 31 Mar 2022 |
| Janus Henderson Group Ltd. |
13F
Company
|
—
denominator unverified
|
$27,238,000
2,001,442 shares
|
— | 31 Mar 2022 |
| Avidity Partners Management LP |
13F
Company
|
—
denominator unverified
|
$26,485,000
1,946,000 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$26,441,000
1,942,701 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
88
Shares
27,258,631
Rows available
88
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
74
Q2 2022 holders
88
Holder diff
14
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend